Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interpretable Prediction of Pancreatic Neoplasms in Chronic Pancreatitis Patients With Focal Pancreatic Lesions Based on XGBoost Machine Learning and SHAP

NCT07045181 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07045181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07045181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interpretable Prediction of Pancreatic Neoplasms in Chronic Pancreatitis Patients With Focal Pancreatic Lesions Based on XGBoost Machine Learning and SHAP
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2025
Completion date
August 5, 2025
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, machine learning, pancreatic neoplasm